Yeji
FDA approvalconf 0.70

FDA approval

$CABA · Cabaletta Bio, Inc.
Event date
Date TBD
Sponsor runway
8 mo
$116.6M liquid

Evidence

“Cabaletta's plans to submit a BLA for rese-cel in myositis in 2027 and obtain regulatory approval from the FDA and other regulatory authorities, among others.”
Source: 8-K filed 2026-01-12View on EDGAR ↗0001193125-26-009819

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

No insider Form 4 activity reported on $CABA in the 90 days around this event.
← All catalysts for $CABA